B of A Securities analyst John Murphy downgrades Sonic Automotive (NYSE:SAH) from Buy to Underperform.
Goldman Sachs Upgrades Magenta Therapeutics to Buy, Raises Price Target to $8
Goldman Sachs analyst Madhu Kumar upgrades Magenta Therapeutics (NASDAQ:MGTA) from Neutral to Buy and raises the price target from $7 to $8.